Facebook Twitter LinkedIn Google Plus RSS

Chugai Pharma USA appoints chief medical officer

By ,

Berkeley Heights-based Chugai Pharma USA LLC, a subsidiary of Tokyo, Japan-based Chugai Pharmaceutical Co. Ltd., announced Friday the appointment of Athos Gianella-Borradori, M.D. as the chief medical officer of CPUSA.

According to the announcement, Dr. Gianella-Borradori has more than 20 years of experience in international drug research and development.  He’s held senior level positions in research and development at Novartis (Switzerland), Crucell (The Netherlands), Bavarian Nordic (Germany), Cyclacel (United Kingdom), Merck Serono (Switzerland), and Clavis Pharma (Norway).

He is responsible for all clinical activity in the U.S.  He represents CPUSA in relationships with the FDA, academia, clinical investigators and patient communities, CPUSA said.  He is also responsible for increasing the awareness of the company’s achievements.

ALSO ON NJBIZ:

NJPP report recommends extending 7 percent sales tax to gas

Most-read April 24: Mack-Cali sells Wyndham's Parsippany headquarters in $97M deal

Jersey companies honored as best in the nation for diversity

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!